Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.
暂无分享,去创建一个
D. Giannarelli | L. di Lauro | F. Calabresi | M. di Palma | P. Marolla | C. Curcio | C. Foggi | G. Paoletti | A. Calabró | M. Di Palma | P. Ballatore